
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16673113
[patent_doc_number] => 20210061876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => T CELL RECEPTORS FOR TUMOR SPECIFIC PROTEASOME SPLICE VARIANTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/958604
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958604 | T CELL RECEPTORS FOR TUMOR SPECIFIC PROTEASOME SPLICE VARIANTS AND USES THEREOF | Jan 1, 2019 | Abandoned |
Array
(
[id] => 14464829
[patent_doc_number] => 20190184054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/233378
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16233378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/233378 | COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION | Dec 26, 2018 | Abandoned |
Array
(
[id] => 19608911
[patent_doc_number] => 12157777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Optimised compounds
[patent_app_type] => utility
[patent_app_number] => 16/768341
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 29984
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768341 | Optimised compounds | Dec 20, 2018 | Issued |
Array
(
[id] => 19608911
[patent_doc_number] => 12157777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Optimised compounds
[patent_app_type] => utility
[patent_app_number] => 16/768341
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 29984
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768341 | Optimised compounds | Dec 20, 2018 | Issued |
Array
(
[id] => 19608911
[patent_doc_number] => 12157777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Optimised compounds
[patent_app_type] => utility
[patent_app_number] => 16/768341
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 29984
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768341 | Optimised compounds | Dec 20, 2018 | Issued |
Array
(
[id] => 19608911
[patent_doc_number] => 12157777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Optimised compounds
[patent_app_type] => utility
[patent_app_number] => 16/768341
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 29984
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768341 | Optimised compounds | Dec 20, 2018 | Issued |
Array
(
[id] => 18980373
[patent_doc_number] => 11905533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Methods and compositions for delivery of viral vectors across the blood-brain barrier
[patent_app_type] => utility
[patent_app_number] => 16/956306
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 45
[patent_no_of_words] => 36427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956306 | Methods and compositions for delivery of viral vectors across the blood-brain barrier | Dec 18, 2018 | Issued |
Array
(
[id] => 18085531
[patent_doc_number] => 11535649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Peptides and other agents for treating pain and increasing pain sensitivity
[patent_app_type] => utility
[patent_app_number] => 16/771204
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 16
[patent_no_of_words] => 16004
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771204 | Peptides and other agents for treating pain and increasing pain sensitivity | Dec 12, 2018 | Issued |
Array
(
[id] => 14069385
[patent_doc_number] => 20190083580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => USE OF ENDOSTATIN PEPTIDES FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/200478
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16200478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/200478 | Use of endostatin peptides for the treatment of fibrosis | Nov 25, 2018 | Issued |
Array
(
[id] => 13982517
[patent_doc_number] => 20190060416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY
[patent_app_type] => utility
[patent_app_number] => 16/190456
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/190456 | Surfactant protein D for the treatment of disorders associated with lung injury | Nov 13, 2018 | Issued |
Array
(
[id] => 17392486
[patent_doc_number] => 11241474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Prebiotic oral care compositions containing amino acids
[patent_app_type] => utility
[patent_app_number] => 16/185632
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9270
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/185632 | Prebiotic oral care compositions containing amino acids | Nov 8, 2018 | Issued |
Array
(
[id] => 16572163
[patent_doc_number] => 10894074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Multi-factor hair growth formulation
[patent_app_type] => utility
[patent_app_number] => 16/178693
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4594
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178693 | Multi-factor hair growth formulation | Nov 1, 2018 | Issued |
Array
(
[id] => 16238254
[patent_doc_number] => 20200255488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Vault Particles Having a Modified R8 Flexible Region
[patent_app_type] => utility
[patent_app_number] => 16/759325
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759325 | Vault particles having a modified R8 flexible region | Oct 29, 2018 | Issued |
Array
(
[id] => 14929857
[patent_doc_number] => 20190300566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHODS OF PURIFYING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/167364
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16167364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/167364 | METHODS OF PURIFYING POLYPEPTIDES | Oct 21, 2018 | Abandoned |
Array
(
[id] => 18341894
[patent_doc_number] => 11639368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Method for preventing and treating hyperpermeability
[patent_app_type] => utility
[patent_app_number] => 16/165392
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 8432
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165392 | Method for preventing and treating hyperpermeability | Oct 18, 2018 | Issued |
Array
(
[id] => 14655639
[patent_doc_number] => 20190234948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => COMPOSITIONS AND METHODS RELATED TO THE METHYLATION OF HISTONE H1.0 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/164701
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/164701 | Compositions and methods related to the methylation of histone H1.0 protein | Oct 17, 2018 | Issued |
Array
(
[id] => 14338965
[patent_doc_number] => 20190151455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 16/160595
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160595 | ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS | Oct 14, 2018 | Abandoned |
Array
(
[id] => 16703200
[patent_doc_number] => 10953114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
[patent_app_type] => utility
[patent_app_number] => 16/157961
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2279
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157961 | Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment | Oct 10, 2018 | Issued |
Array
(
[id] => 14158709
[patent_doc_number] => 20190106457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => METHOD FOR PREPARING S-Bz-MAG3 AS A PRECURSOR OF CONTRAST MEDIA
[patent_app_type] => utility
[patent_app_number] => 16/157277
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157277 | Method for preparing S-Bz-MAG3 as a precursor of contrast media | Oct 10, 2018 | Issued |
Array
(
[id] => 18620430
[patent_doc_number] => 11753458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => CTLA-4 variant immunomodulatory proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/755072
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 75275
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755072 | CTLA-4 variant immunomodulatory proteins and uses thereof | Oct 8, 2018 | Issued |